See more : CN Energy Group. Inc. (CNEY) Income Statement Analysis – Financial Results
Complete financial analysis of Sweet Earth Holdings Corporation (SEHCF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sweet Earth Holdings Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Deneb Investments Limited (DNB.JO) Income Statement Analysis – Financial Results
- Park National Corporation (PRK) Income Statement Analysis – Financial Results
- Pantera Minerals Limited (PFE.AX) Income Statement Analysis – Financial Results
- Magna Mining Inc. (NICU.V) Income Statement Analysis – Financial Results
- Arisz Acquisition Corp. (ARIZR) Income Statement Analysis – Financial Results
Sweet Earth Holdings Corporation (SEHCF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://sweetearthskincare.com
About Sweet Earth Holdings Corporation
Sweet Earth Holdings Corporation cultivates, processes, and sells hemp cannabidiol (CBD) products in the United States and Spain. The company offers CBD and hemp infused facial products, including CBD hydration creams, oat and honey cleansers, and soothing CBD lip balms; and botanicals and essential oils, such as balancing CBD jasmine oils, soothing CBD bath salt soaks, invigorating CBD neem and turmeric scrubs, and aloe-infused CBD hand sanitizers for body and skin care. It also provides beard and face care products for men comprising CBD face cleansers, shaving creams, aftershave creams, beard and face oils, and styling balms; hemp products; CBD pre-rolls; and CBD dog treats consisting of garbanzo, flour, potato flakes, cheddar cheese, full spectrum hemp oil, natural beef flavor, MCT coconut oil, and mixed tocopherols. The company is based in Vancouver, Canada.
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 9.67K | 42.25K | 88.12K | 200.73K | 0.00 | 0.00 |
| Cost of Revenue | 4.10K | 11.95K | 66.16K | 93.17K | 231.81K | 61.87K |
| Gross Profit | 5.58K | 30.30K | 21.96K | 107.56K | -231.81K | -61.87K |
| Gross Profit Ratio | 57.66% | 71.71% | 24.92% | 53.58% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 306.32K | 322.64K | 904.88K | 1.28M | 3.70M | 2.50M |
| Selling & Marketing | 13.03K | 22.31K | 147.24K | 2.65M | 356.07K | 635.37K |
| SG&A | 319.35K | 344.95K | 1.05M | 3.94M | 4.06M | 2.11M |
| Other Expenses | 19.34K | 187.14K | -10.72K | -751.51K | -1.14M | 0.00 |
| Operating Expenses | 338.69K | 532.09K | 1.31M | 4.19M | 3.59M | 2.11M |
| Cost & Expenses | 342.78K | 544.04K | 1.38M | 4.28M | 3.59M | 2.17M |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 226.00 | 44.07K | 66.53K | 88.07K | 140.00K | 26.76K |
| Depreciation & Amortization | 516.26K | 117.31K | 232.95K | 248.37K | 231.81K | 61.87K |
| EBITDA | 183.15K | -340.40K | -1.05M | -4.71M | -3.47M | -3.71M |
| EBITDA Ratio | 1,893.79% | -805.61% | -1,196.68% | -1,907.99% | 0.00% | 0.00% |
| Operating Income | -333.11K | -381.83K | -1.35M | -414.28K | 951.55K | -2.17M |
| Operating Income Ratio | -3,444.43% | -903.64% | -1,536.55% | -206.39% | 0.00% | 0.00% |
| Total Other Income/Expenses | 516.03K | 263.96K | -1.79M | -325.98K | -114.02K | -1.60M |
| Income Before Tax | 182.92K | -117.87K | -3.15M | -4.92M | -4.87M | -2.20M |
| Income Before Tax Ratio | 1,891.45% | -278.95% | -3,571.29% | -2,450.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 66.53K | 88.07K | -1.00M | 3.00 |
| Net Income | 182.92K | -117.87K | -3.15M | -4.92M | -4.87M | -2.20M |
| Net Income Ratio | 1,891.45% | -278.95% | -3,571.29% | -2,450.00% | 0.00% | 0.00% |
| EPS | 0.00 | -0.04 | -1.16 | -2.51 | -3.00 | -1.11 |
| EPS Diluted | 0.00 | -0.04 | -1.16 | -2.51 | -3.00 | -1.11 |
| Weighted Avg Shares Out | 0.00 | 3.30M | 2.71M | 1.96M | 1.62M | 1.99M |
| Weighted Avg Shares Out (Dil) | 0.00 | 3.30M | 2.71M | 1.96M | 1.62M | 1.99M |
RETRANSMISSION: Sweet Earth Finalizing INVIMA Approval for South America
Sweet Earth Finalizing INVIMA Approval for South America
RETRANSMISSION: Sweet Earth Commences Key CBD Bioavailability Research
Sweet Earth Commences Key CBD Bioavailability Research
RETRANSMISSION: Sweet Earth and Frosty's Extracts LLC Enter into Supply Arrangement Agreement
Sweet Earth and Frosty's Extracts LLC Enter into Supply Arrangement Agreement
RETRANSMISSION: Sweet Earth Launches Line of CBD Cigarettes Sold Under Proprietary Brand Name Sweet Earth Smooth
Sweet Earth Launches Line of CBD Cigarettes Sold Under Proprietary Brand Name Sweet Earth Smooth
RETRANSMISSION: Shark Discoveries Completes Sweet Earth Commercial and Launches Sales Campaign
Shark Discoveries Completes Sweet Earth Commercial and Launches Sales Campaign
Source: https://incomestatements.info
Category: Stock Reports